86 related articles for article (PubMed ID: 3253050)
21. Phagocytosis and intracellular killing of rokitamycin-exposed staphylococci by human polymorphonuclear leukocytes.
Braga PC; Sala MT; Mancini L; Da Sasso M
Chemotherapy; 1998; 44(1):42-9. PubMed ID: 9444408
[TBL] [Abstract][Full Text] [Related]
22. Interactions among antibiotics, bacteria and the human immune system: the clinical relevance of in vitro testing.
Bergogne-Berezin E
J Chemother; 1997 May; 9 Suppl 1():109-15. PubMed ID: 9248969
[TBL] [Abstract][Full Text] [Related]
23. Serial studies of leukocyte chemiluminescence: lack of effect of macrolide antibiotic therapy.
Martin RR; Putman M; Greenberg SB; Wallace RJ; Wilson SZ
J Med; 1980; 11(1):39-48. PubMed ID: 6995547
[TBL] [Abstract][Full Text] [Related]
24. Influence of teicoplanin on the chemiluminescence of phagocytosing human granulocytes.
Aquilini D; Bartoloni A; Paradisi F
J Chemother; 1991 Jan; 3 Suppl 1():119-21. PubMed ID: 12041744
[TBL] [Abstract][Full Text] [Related]
25. The influence of foreign bodies on the in vitro activity of various antibiotics against S. aureus, S. epidermidis and gram-negative strains.
Kropec A; Ricke B; Engels I; Eisele S; Daschner F
J Chemother; 1989 Jul; 1(4 Suppl):7. PubMed ID: 16312281
[No Abstract] [Full Text] [Related]
26. [Are we being threatened by multiresistant strains of Staphylococcus aureus?].
Aepfelbacher M
MMW Fortschr Med; 2005 Jan; 147(4):33-5, 37. PubMed ID: 15745339
[TBL] [Abstract][Full Text] [Related]
27. [Nosocomial catheter-related sepsis secondary to central venous catheters].
Wu H; Wu Z; Jin D; Xu J
Zhonghua Wai Ke Za Zhi; 1999 Nov; 37(11):651-3. PubMed ID: 11829916
[TBL] [Abstract][Full Text] [Related]
28. Adverse effect of staphylococci slime on in vitro activity of glycopeptides.
Mathur T; Singhal S; Khan S; Upadhyay D; Fatma T; Rattan A
Jpn J Infect Dis; 2005 Dec; 58(6):353-7. PubMed ID: 16377866
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
30. The role of vancomycin in the treatment paradigm.
Stevens DL
Clin Infect Dis; 2006 Jan; 42 Suppl 1():S51-7. PubMed ID: 16323121
[TBL] [Abstract][Full Text] [Related]
31. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
Chang FY; Peacock JE; Musher DM; Triplett P; MacDonald BB; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
Medicine (Baltimore); 2003 Sep; 82(5):333-9. PubMed ID: 14530782
[TBL] [Abstract][Full Text] [Related]
32. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.
Wiederhold NP; Coyle EA; Raad II; Prince RA; Lewis RE
J Antimicrob Chemother; 2005 May; 55(5):792-5. PubMed ID: 15814598
[TBL] [Abstract][Full Text] [Related]
33. The use of intradiscal antibiotics for discography: an in vitro study of gentamicin, cefazolin, and clindamycin.
Klessig HT; Showsh SA; Sekorski A
Spine (Phila Pa 1976); 2003 Aug; 28(15):1735-8. PubMed ID: 12897501
[TBL] [Abstract][Full Text] [Related]
34. Antibacterial activation of hydroxyapatite (HA) with controlled porosity by different antibiotics.
Chai F; Hornez JC; Blanchemain N; Neut C; Descamps M; Hildebrand HF
Biomol Eng; 2007 Nov; 24(5):510-4. PubMed ID: 17869175
[TBL] [Abstract][Full Text] [Related]
35. Staphylococcus epidermidis with intermediate resistance to vancomycin: elusive phenotype or laboratory artifact?
Dunne WM; Qureshi H; Pervez H; Nafziger DA
Clin Infect Dis; 2001 Jul; 33(1):135-7. PubMed ID: 11389509
[TBL] [Abstract][Full Text] [Related]
36. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic sensitivity testing: correlations between in vitro tests in vivo situations.
Devriese LA; Dutta GN
Ann Rech Vet; 1981; 12(1):41-6. PubMed ID: 7044256
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model.
LaPlante KL; Mermel LA
Nephrol Dial Transplant; 2007 Aug; 22(8):2239-46. PubMed ID: 17403700
[TBL] [Abstract][Full Text] [Related]
39. Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization.
Shah A; Mond J; Walsh S
Antimicrob Agents Chemother; 2004 Jul; 48(7):2704-7. PubMed ID: 15215130
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.
Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Licci A; Nadolski P; Riva A; Lukasiak J; Scalise G
Int J Antimicrob Agents; 2005 Sep; 26(3):235-40. PubMed ID: 16122911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
